Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease.

Inflammatory Bowel Diseases
Bruce E SandsSusan Greenbloom

Abstract

Interleukin-12 (IL-12) and interleukin-23 (IL-23) are inflammatory cytokines linked to the Th-1 and Th-17 phenotypes associated with Crohn's disease (CD). We investigated the activity and safety of apilimod mesylate (formerly STA-5326), an oral IL-12 and IL-23 inhibitor, in patients with active CD. We performed a multicenter, Phase 2, randomized, double-blinded, placebo-controlled study to evaluate the efficacy of apilimod mesylate in treating 220 adult patients with moderate-to-severe CD (Crohn's Disease Activity Index [CDAI] score 220-450). Patients were stratified according to C-reactive protein (CRP) levels and corticosteroid use and were randomly assigned to receive placebo or apilimod mesylate 50 mg daily or 100 mg daily. The study was divided into an induction phase (43 days) and a maintenance phase (125 days). The primary analysis involved a comparison of the proportion of patients experiencing clinical response, defined as at least a 100-point decrease in CDAI score from baseline at day 29. Data on adverse events were also collected. In all, 220 of the planned 282 patients were enrolled when the Data Monitoring Committee determined that the drug was not efficacious as a treatment and closed enrollment. A clinical respo...Continue Reading

References

Feb 4, 2003·Nature Reviews. Immunology·Giorgio Trinchieri
Nov 13, 2004·The New England Journal of Medicine·Peter J MannonUNKNOWN Anti-IL-12 Crohn's Disease Study Group
Dec 27, 2005·Inflammatory Bowel Diseases·Stephen B Hanauer
May 4, 2006·The Journal of Clinical Investigation·Yoichiro Iwakura, Harumichi Ishigame
Jul 5, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·R Balfour Sartor
Sep 29, 2006·World Journal of Gastroenterology : WJG·Ilaria PelusoGiovanni Monteleone
Jan 9, 2007·Nature Medicine·Markus F Neurath
Feb 13, 2007·Annual Review of Immunology·Robert A KasteleinDaniel J Cua
Jul 27, 2007·Nature·R J Xavier, D K Podolsky
Aug 19, 2008·Gastroenterology·William J SandbornUNKNOWN Ustekinumab Crohn's Disease Study Group

❮ Previous
Next ❯

Citations

May 10, 2011·Drug Design, Development and Therapy·John K TriantafillidisFilippos Georgopoulos
Feb 26, 2011·World Journal of Gastroenterology : WJG·Guillaume BouguenLaurent Peyrin-Biroulet
Jan 15, 2014·Expert Review of Gastroenterology & Hepatology·Alessia SettesoldiVito Annese
Jan 15, 2014·Expert Review of Clinical Immunology·Keil AuerDario Sorrentino
May 3, 2011·Expert Opinion on Emerging Drugs·Nicolino Ruperto, Alberto Martini
Aug 3, 2011·British Journal of Pharmacology·Flavio CaprioliGiovanni Monteleone
Aug 9, 2011·Biochemical Pharmacology·Mac A Johnson, Raymond J Winquist
Jun 25, 2016·Expert Opinion on Biological Therapy·E G SimonG W Moran
Jun 30, 2016·Expert Opinion on Therapeutic Targets·Markus JoergerSteven G Gray
Nov 8, 2016·Expert Opinion on Biological Therapy·Bram VerstocktMarc Ferrante
Apr 18, 2012·Inflammatory Bowel Diseases·Thomas T MacDonaldGiovanni Monteleone
Nov 26, 2016·The Cochrane Database of Systematic Reviews·John K MacDonaldAntje Timmer
Nov 8, 2011·Immunotherapy·Clémentine Perrier, Paul Rutgeerts
Feb 6, 2010·Nature Reviews. Gastroenterology & Hepatology·Gil Y Melmed, Stephan R Targan
Sep 4, 2019·Nature Reviews. Drug Discovery·Srinivasa Reddy BonamSylviane Muller
Dec 13, 2019·The Cochrane Database of Systematic Reviews·Sarah C DaviesReena Khanna
Feb 26, 2011·American Journal of Clinical Dermatology·Marta KurzejaMalgorzata Olszewska
Nov 4, 2015·World Journal of Gastroenterology : WJG·Gonzalo Jesús Gómez-GómezBegoña Casís
Oct 20, 2018·Assay and Drug Development Technologies·Hermann A M Mucke
Mar 7, 2017·Immune Network·Duk Hwan Kim, Jae Hee Cheon
Mar 5, 2019·Alimentary Pharmacology & Therapeutics·Heather CattKeith Bodger
Aug 9, 2020·Proceedings of the National Academy of Sciences of the United States of America·Yuan-Lin KangTom Kirchhausen
May 29, 2015·World Journal of Gastroenterology : WJG·Cristina-Sorina CătanăDan Lucian Dumitraşcu
Feb 7, 2017·Alimentary Pharmacology & Therapeutics·V JairathB G Feagan
Jan 10, 2017·Expert Review of Clinical Immunology·Federica FurfaroSilvio Danese
Apr 14, 2017·PLoS Neglected Tropical Diseases·Elizabeth A NelsonJudith M White
Jul 26, 2012·Clinical Pharmacology and Therapeutics·D A KatzkaM Camilleri
Jan 15, 2014·The Journal of Biological Chemistry·Rainer GlaubenBritta Siegmund
Sep 11, 2012·Journal of Leukocyte Biology·M Merle EllosoAnne M Fourie
Feb 5, 2021·Journal of Medicinal Chemistry·Rinky Raghuvanshi, Sandip B Bharate
Dec 31, 2020·Viruses·Stephen D Carro, Sara Cherry
Oct 20, 2019·Toxicology and Applied Pharmacology·Ognian C IkonomovAssia Shisheva
Apr 20, 2019·Current Opinion in Virology·Megan R Edwards, Christopher F Basler
Oct 29, 2020·ACS Infectious Diseases·Anil Mathew TharappelHongmin Li
Apr 7, 2019·Trends in Molecular Medicine·Sruthi Vijaya Retnakumar, Sylviane Muller
May 11, 2021·Journal of Medicinal Chemistry·Javier García-CárcelesAna Martínez
May 20, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Weilian BaoXiaoyan Shen
Aug 3, 2021·Frontiers in Pharmacology·Linshan DuanGuoyan Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.